GlassScriptPhysician profile
Arif S Hussain
NPI 1548554249
$6,423.42
in general payments reported to CMS, 2019-2025
37 companies · $739 in 2025
The $739 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $711 · 2021: $1,364 · 2022: $1,688 · 2023: $33.60 · 2024: $523 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,296.63 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Abbvie INC. | $1,028.01 | 2021-2025 | |
| Novo Nordisk INC | $788.00 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $409.42 | 2019-2024 | Jardiance |
| Lilly USA, LLC | $403.44 | 2019-2025 | Zepbound, Jardiance |
| Allergan, INC. | $332.72 | 2019-2021 | |
| Glaxosmithkline, LLC. | $269.18 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $263.39 | 2019-2022 | |
| Amgen INC. | $242.65 | 2019-2024 | Otezla, Repatha |
| Alnylam Pharmaceuticals INC. | $150.00 | 2025 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $131.24 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.81 | 2019-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $126.85 | 2019-2022 | |
| Pfizer INC. | $108.36 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.22 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $91.04 | 2019-2021 | |
| Amarin Pharma, INC. | $61.97 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $56.49 | 2022 | |
| Genentech USA, INC. | $53.98 | 2019 | |
| Eisai INC. | $50.35 | 2019-2021 | |
| Stimwave Technologies Incorporated | $29.17 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.70 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $26.19 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $25.96 | 2021 | |
| Shield Therapeutics INC | $25.45 | 2022 | |
| Sunovion Pharmaceuticals INC. | $24.24 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $23.55 | 2019 | |
| Exact Sciences Corporation | $17.48 | 2023 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $16.24 | 2024 | |
| Sanofi Pasteur INC. | $14.98 | 2021 | |
| Almatica Pharma LLC | $14.81 | 2022 | |
| Xeris Pharmaceuticals, INC. | $14.53 | 2021 | |
| Ibsa Pharma INC. | $13.96 | 2022 | |
| Philips North America LLC | $13.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $13.18 | 2022 | |
| Hikma Pharmaceuticals USA | $11.97 | 2019 | |
| Mylan Specialty L.P. | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Hussain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.